Safety and Efficacy Study of Healos as a Bone Replacement to Treat Degenerative Disc Disease
A Prospective, Multicenter, Randomized Study Comparing the Use of HEALOS® to Autograft in a Transforaminal Lumbar Interbody Fusion (TLIF) Approach
Sponsor: Advanced Technologies and Regenerative Medicine, LLC (ATRM)
Listed as NCT00316121, this PHASE3 trial focuses on Degenerative Disc Disease and remains completed. Sponsored by Advanced Technologies and Regenerative Medicine, LLC (ATRM), it has been updated 7 times since 2006, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Dec 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Dec 2021 [monthly]
Completed PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
▶ Show 2 earlier versions
-
Feb 2017 — Jun 2018 [monthly]
Completed PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE3
First recorded
Apr 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Advanced Technologies and Regenerative Medicine, LLC (ATRM)
- DePuy Spine
For direct contact, visit the study record on ClinicalTrials.gov .